0000719135-23-000040.txt : 20230629 0000719135-23-000040.hdr.sgml : 20230629 20230629164204 ACCESSION NUMBER: 0000719135-23-000040 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230626 FILED AS OF DATE: 20230629 DATE AS OF CHANGE: 20230629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hornsby Todd CENTRAL INDEX KEY: 0001764505 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31885 FILM NUMBER: 231058019 MAIL ADDRESS: STREET 1: 14321 HAWTHORNE DR. CITY: CARMEL STATE: IN ZIP: 46033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apyx Medical Corp CENTRAL INDEX KEY: 0000719135 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112644611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5115 ULMERTON ROAD CITY: CLEARWATER STATE: FL ZIP: 33760 BUSINESS PHONE: 7273842323 MAIL ADDRESS: STREET 1: 5115 ULMERTON ROAD CITY: CLEARWATER STATE: FL ZIP: 33760 FORMER COMPANY: FORMER CONFORMED NAME: BOVIE MEDICAL Corp DATE OF NAME CHANGE: 20150319 FORMER COMPANY: FORMER CONFORMED NAME: BOVIE MEDICAL CORP DATE OF NAME CHANGE: 19990216 FORMER COMPANY: FORMER CONFORMED NAME: AN CON GENETICS INC DATE OF NAME CHANGE: 19920703 4/A 1 wk-form4a_1688071316.xml FORM 4/A X0407 4/A 2023-06-26 2023-06-28 0 0000719135 Apyx Medical Corp APYX 0001764505 Hornsby Todd C/O APYX MEDICAL CORPORATION 5115 ULMERTON ROAD CLEARWATER FL 33760 0 1 0 0 Executive Vice President 1 Common Stock 2023-06-26 4 M 0 15000 1.77 A 15000 D Common Stock 2023-06-26 4 S 0 15000 7.56 D 0 D Stock Option (Option to Buy) 1.77 2023-06-26 4 M 0 15000 0 D 2019-12-18 2025-12-17 Common Stock 15000 20000 D The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023 This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. The original Form 4 is hereby amended to correct the amount of securities beneficially owned by the Reporting Person (as set forth in Column 5 of Table I) following the previously reported transactions Todd Hornsby 2023-06-29